About the Authors

Otto O. Yang

Contributed equally to this work with: Otto O. Yang, F. Javier Ibarrondo, Peter A. Anton

OYang@mednet.ucla.edu

Affiliations Department of Medicine and University of California Los Angeles AIDS Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America, Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America, AIDS Healthcare Foundation, Los Angeles, California, United States of America

F. Javier Ibarrondo

Contributed equally to this work with: Otto O. Yang, F. Javier Ibarrondo, Peter A. Anton

Affiliation Department of Medicine and University of California Los Angeles AIDS Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

Charles Price

Affiliation Department of Medicine and University of California Los Angeles AIDS Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

Lance E. Hultin

Affiliation Department of Medicine and University of California Los Angeles AIDS Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

Julie Elliott

Affiliation Department of Medicine and University of California Los Angeles AIDS Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

Patricia M. Hultin

Affiliation Department of Medicine and University of California Los Angeles AIDS Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

Roger Shih

Affiliation Department of Medicine and University of California Los Angeles AIDS Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

Mary Ann Hausner

Affiliation Department of Medicine and University of California Los Angeles AIDS Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

Hwee L. Ng

Affiliation Department of Medicine and University of California Los Angeles AIDS Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

Jennifer Hoffman

Affiliation Department of Medicine and University of California Los Angeles AIDS Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

Beth D. Jamieson

Affiliation Department of Medicine and University of California Los Angeles AIDS Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

Peter A. Anton

Contributed equally to this work with: Otto O. Yang, F. Javier Ibarrondo, Peter A. Anton

Affiliation Department of Medicine and University of California Los Angeles AIDS Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

Competing Interests

Sanofi Pasteur specifically provided the GMP vaccine and placebo, and performed the ELISAs for anti-Canarypox antibodies. Otherwise, they provided no financial support related to this study. Requests for vCP205 vaccine and canarypox ELISA reagents would need to be directed to Sanofi Pasteur, but otherwise this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: OY FI JE BJ PA. Performed the experiments: FI LH JE PH RS MH HN. Analyzed the data: OY FI LH JE JH BJ PA. Contributed reagents/materials/analysis tools: CP PA. Wrote the paper: OY FI JH BJ PA. Clinical trial administrative management: CP.